RVPH - MCAP CO - Reviva Pharmaceuticals

This price chart for Reviva Pharmaceuticals (RVPH) illustrates the price action of an asset with a market capitalization of . Reviva Pharmaceuticals (RVPH) faces a capital shortage and a lack of profitability while awaiting the results of key tests for its schizophrenia drug. The business focuses on developing safe treatments for CNS disorders and psoriasis, while adhering to strict laboratory waste disposal regulations.

Reviva Pharmaceuticals focuses on neurology, outsourcing its production and trials to third-party contractors. The company's current market capitalization reflects the market value of all the issuer's shares. This calculated metric allows for the exclusion of speculative expectations to assess the business's actual margin of safety. The trend of this indicator is critical for monitoring delisting risks under negative scenarios. The final value determines the company's fundamental stability in the face of systemic degradation.